Labcorp Files Routine 8-K Confirming NYSE Listing
Ticker: LH · Form: 8-K · Filed: Jan 2, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, administrative, stock-listing
TL;DR
**Labcorp's 8-K is a standard procedural filing, no new news for investors.**
AI Summary
Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on January 2, 2024, to report an event that occurred on the same date. This filing is a routine disclosure, primarily indicating that the company's Common Stock, with a $0.10 par value, is registered on the New York Stock Exchange under the trading symbol LH. For investors, this filing simply confirms the company's current listing status and does not contain any new material financial or operational information that would immediately impact stock valuation.
Why It Matters
This filing is a standard procedural update and does not contain new information that would affect an investor's decision, as it merely confirms existing public knowledge about Labcorp's stock listing.
Risk Assessment
Risk Level: low — This 8-K filing is purely administrative and does not introduce any new financial, operational, or legal risks to the company.
Analyst Insight
A smart investor would recognize this as a non-material administrative filing and would not take any immediate action based solely on this information, as it provides no new insights into the company's financial performance or strategic direction.
Key Numbers
- $0.10 — Common Stock Par Value (the stated par value per share of Labcorp's common stock)
Key Players & Entities
- LABORATORY CORPORATION OF AMERICA HOLDINGS (company) — the registrant filing the 8-K
- New York Stock Exchange (company) — where Labcorp's common stock is registered
- $0.10 (dollar_amount) — par value of common stock
FAQ
What is the purpose of this specific 8-K filing by Laboratory Corporation of America Holdings?
This 8-K filing, dated January 2, 2024, is a routine current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. It primarily serves to confirm the registration of the company's Common Stock on the New York Stock Exchange.
What is the trading symbol for Laboratory Corporation of America Holdings' common stock?
The trading symbol for Laboratory Corporation of America Holdings' Common Stock is LH, as stated in the filing under 'Title of Each Class' and 'Trading Symbol'.
On which exchange is Laboratory Corporation of America Holdings' common stock registered?
Laboratory Corporation of America Holdings' Common Stock is registered on the New York Stock Exchange, as indicated in the filing under 'Name of exchange on which registered'.
What is the par value of the Common Stock mentioned in the filing?
The par value of the Common Stock is $0.10, as specified in the filing under 'Title of Each Class'.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is January 2, 2024, as stated at the beginning of the Form 8-K document.
Filing Stats: 436 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-01-02 07:48:30
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240102.htm (8-K) — 26KB
- formpr1224ex991jpmorganhcc.htm (EX-99.1) — 5KB
- lc2020logov2a.gif (GRAPHIC) — 5KB
- 0000920148-24-000002.txt ( ) — 161KB
- lh-20240102.xsd (EX-101.SCH) — 2KB
- lh-20240102_lab.xml (EX-101.LAB) — 23KB
- lh-20240102_pre.xml (EX-101.PRE) — 12KB
- lh-20240102_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9 at 4:30 p.m. (PT). A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated January 2 , 202 4 issued by Labcorp
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary January 2, 2024